Latest MS Stories
According to new report from BCC Research,the global market for multiple sclerosis (MS) disease-modifying products reached nearly $10.9 billion in 2013.
HIV infection is linked to a significantly lower risk of developing multiple sclerosis (MS).
-- Oral Presentation to Include Greater Detail on Clinical Outcomes, Including Significant and Unique Improvements in Cognition -- ROCKVILLE, Md., July 31, 2014 /PRNewswire/ -- Synthetic
DailyGossip.org reveals in its latest review that a new program, the Natural Multiple Sclerosis Treatment, has been developed for sufferers to access a natural, safe way of stopping multiple sclerosis.
Genzyme/Sanofi's Lemtrada and Genentech/Roche's Ocrelizumab Will Likely Be Reserved for Patients with Aggressive/Severe MS, According to Findings from Decision Resources Group BURLINGTON, Mass.,
FAIRFIELD, Conn., July 22, 2014 /PRNewswire/ -- An estimated 2.3 million people worldwide live with multiple sclerosis
CINCINNATI, July 21, 2014 /PRNewswire/ -- An estimated 2.3 million people worldwide live with multiple sclerosis
Every Month Hands-On Physical Therapy Raises Money for an Important Cause: This Month Was the Fight Against Multiple Sclerosis Astoria, New York (PRWEB) July
More Images (2 images) »